Russell Kern
Net Worth

Last updated:

What is Russell Kern net worth?

The estimated net worth of Dr. Russell Kern is at least $951,564 as of 3 Dec 2018. He owns shares worth $32,112 as insider, has earned $1,962 from insider trading and has received compensation worth at least $917,490 in International Stem Cell Corporation.

What is the salary of Russell Kern?

Dr. Russell Kern salary is $53,970 per year as Executive Vice President, Chief Scientific Officer & Director in International Stem Cell Corporation.

How old is Russell Kern?

Dr. Russell Kern is 39 years old, born in 1986.

What stocks does Russell Kern currently own?

As insider, Dr. Russell Kern owns shares in one company:

Company Title Shares Price per share Total value
International Stem Cell Corporation (ISCO) Executive Vice President, Chief Scientific Officer & Director 178,398 $0.18 $32,112

What does International Stem Cell Corporation do?

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products. The company's human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. The company sells skincare products through a website and professional channels; and human cell culture products through its sales force, OEM partners, and brand distributors. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.

ISCO logo
ISCO
International Stem Cell Corporation
$0.18

Russell Kern insider trading

International Stem Cell Corporation

Dr. Russell Kern has made only one insider trade between 2008-2018, according to the Form 4 filled with the SEC.

As of 3 Dec 2018 he still owns at least 178,398 units of ISCO stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Option (Right to Buy) 1,800 $1.09 $1,962
Option
Common Stock 1,800 $1.09 $1,962
Sale
Common Stock 1,800 $1.09 $1,962
Option
Common Stock 27,500 $1.09 $29,975
Option
Stock Options (Right to Buy) 27,500 N/A N/A
Option
Common Stock 8,889 $1.1 $9,778
Option
Stock Options (Right to Buy) 8,889 N/A N/A
Purchase
Common Stock 1,861,331 $0.05 $83,760
Purchase
Common Stock 1,861,331 $0.05 $83,760
Purchase
Series A Warrant (Right to Buy) 1,861,331 N/A N/A
Purchase
Series H-2 Preferred Stock 120 $0.06 $8
Purchase
Common Stock 555,556 $0.09 $50,000
Purchase
Common Stock 1,000,000 $0.1 $100,000
Purchase
Common Stock 700,000 $0.1 $70,000
Option
Series A Warrant (Right to Buy) 1,334,334 $0.15 $200,150
Option
Common Stock 1,601,200 N/A N/A
Purchase
Common Stock 463,333 $0.15 $69,500
Purchase
Common Stock 667,667 $0.15 $100,150
Purchase
Series A Warrant (Right to Buy) 667,667 $0.15 $100,150
Purchase
Series G Preferred Stock 5,000,000 $0.4 $2,000,000
Purchase
Class D Convertible Preferred Stock 10 $0.25 $3
Purchase
Class C Convertible Preferred Stock 1,300,000 $0.25 $325,000

International Stem Cell key executives

International Stem Cell Corporation executives and other stock owners filed with the SEC: